Browse
related articles
Bahrain pharmaceutical market at $118m by 2013
- Bahrain: Thursday, August 13 - 2009 at 10:44
According to a report by Research and Markets, Bahrain's total pharmaceuticals market value is expected to increase from $115m in 2008, to $118m by 2013, with a compound annual growth rate of only 0.52% in US dollar terms. 'The over-the-counter drug market is expected to undergo a modest decline during our forecast period, with compound annual growth only -1.31% through to 2013,' the report said. The prescription drug market will rise from $102m in 2008 to $106m by 2013, the report said, adding that the kingdom's government is moving slowly toward a more pro-generic drug policy in light of rising prescription prices.
Also consider reading:
Today's top stories
Week's top stories
Digg
Facebook
LinkedIn
Twitter
Browse
related articles
- » Boeing pushes 777 fix
- » Turki AL Shahrani appointed Director of Sales and Marketing for Riyadh Marriott
- » O2 Network celebrates the year's successes at fourth annual gathering in Dubai
- » Fitch: UAE banking sector can absorb bad loan increase
- » Khorfakkan performs record 343 moves per hour on UASC's 'Deira'
StaffThursday, August 13 - 2009 at 10:44 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
It looks like you are using a Mac - check out our 
Web Feeds